{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260531990280/en/Pfizer%E2%80%99s-BRAFTOVI-Regimen-Nearly-Doubles-Median-Progression-Free-Survival-in-Metastatic-Colorectal-Cancer", "message": "News view counter 769192 successfully enlarged"}